Related Experiment Videos
Inhibition of mitogen-induced human lymphocyte responsiveness by polymixin antibiotics
Abstract:
Polymixin antibiotics, polymixin B and polymixin E (colistin) inhibited the mitogen-induced lymphoproliferative response of human lymphocytes. Inhibition of the lymphocyte response to PHA, PWM and Con A was evident at a low concentration of 1 U/ml of antibiotics. Lymphocytes in which the signals for proliferation had occurred were similarly prevented from proliferating. The effects were not due to cell death (toxicity). Since polymixin concentrations at which inhibition of lymphocyte proliferation was observed are employed in tissue culture medium and are also attained in plasma of patients, the results suggest that the use of the antibiotics in lymphocyte cultures limits lymphocyte responsiveness and that patients receiving polymixin antibiotics may experience a state of immunosuppression.
Insights
Polymyxin antibiotics like polymyxin B and colistin (polymyxin E) suppress human lymphocyte proliferation. These findings suggest potential immunosuppression in patients receiving these antibiotics.
Area of Science:
- Immunology
- Microbiology
- Pharmacology
Background:
- Polymyxin antibiotics are crucial for treating multidrug-resistant Gram-negative bacterial infections.
- Their potential impact on the human immune system, particularly lymphocyte function, remains incompletely understood.
Purpose of the Study:
- To investigate the effects of polymyxin B and polymyxin E (colistin) on mitogen-induced human lymphocyte proliferation.
- To determine if observed effects are due to cytotoxicity or direct inhibition of immune response.
Main Methods:
- Human lymphocytes were cultured and stimulated with mitogens (PHA, PWM, Con A).
- The proliferation response was measured in the presence of varying concentrations of polymyxin B and colistin.
- Cell viability assays were performed to assess antibiotic toxicity.
Main Results:
- Polymyxin B and colistin significantly inhibited lymphocyte proliferation at concentrations as low as 1 U/ml.
- Inhibition occurred even after proliferation signals were initiated, indicating a direct impact on the proliferative pathway.
- The observed inhibition was not attributable to antibiotic-induced cell death.
Conclusions:
- Polymyxin antibiotics can suppress human lymphocyte responsiveness.
- Clinical use of polymyxins may lead to a state of immunosuppression in patients.
- The findings highlight the need for careful consideration of immunomodulatory effects in polymyxin therapy.